JP2024542943A5 - - Google Patents

Info

Publication number
JP2024542943A5
JP2024542943A5 JP2024523204A JP2024523204A JP2024542943A5 JP 2024542943 A5 JP2024542943 A5 JP 2024542943A5 JP 2024523204 A JP2024523204 A JP 2024523204A JP 2024523204 A JP2024523204 A JP 2024523204A JP 2024542943 A5 JP2024542943 A5 JP 2024542943A5
Authority
JP
Japan
Prior art keywords
topical composition
composition according
formula
compound
topical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024523204A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542943A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/060058 external-priority patent/WO2023067519A1/en
Publication of JP2024542943A publication Critical patent/JP2024542943A/ja
Publication of JP2024542943A5 publication Critical patent/JP2024542943A5/ja
Pending legal-status Critical Current

Links

JP2024523204A 2021-10-19 2022-10-19 光線力学的療法のための局所用組成物および方法 Pending JP2024542943A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163257175P 2021-10-19 2021-10-19
US63/257,175 2021-10-19
PCT/IB2022/060058 WO2023067519A1 (en) 2021-10-19 2022-10-19 Topical compositions and methods for photodynamic therapy

Publications (2)

Publication Number Publication Date
JP2024542943A JP2024542943A (ja) 2024-11-19
JP2024542943A5 true JP2024542943A5 (https=) 2025-10-20

Family

ID=84245894

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024523204A Pending JP2024542943A (ja) 2021-10-19 2022-10-19 光線力学的療法のための局所用組成物および方法

Country Status (7)

Country Link
US (2) US20230131170A1 (https=)
EP (1) EP4419074A1 (https=)
JP (1) JP2024542943A (https=)
AU (1) AU2022369135A1 (https=)
CA (1) CA3235710A1 (https=)
IL (1) IL312286A (https=)
WO (1) WO2023067519A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2860807T3 (es) 2015-10-15 2021-10-05 Dusa Pharmaceuticals Inc Iluminador ajustable para terapia y diagnóstico fotodinámicos
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy
JP2025537694A (ja) * 2022-11-04 2025-11-20 サン ファーマシューティカル インダストリーズ,インコーポレイテッド 光線力学的療法の方法
WO2025046471A1 (en) * 2023-08-28 2025-03-06 Sun Pharmaceutical Industries, Inc. Photodynamic therapy in combination with an hedgehog pathway inhibitor for use in treating non-melanoma skin cancer
WO2025235557A2 (en) 2024-05-07 2025-11-13 Sun Pharmaceutical Industries, Inc. Photodynamic therapy illuminator and photodynamic therapy methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954703A (en) 1997-10-31 1999-09-21 Dusa Pharmaceuticals, Inc. Method and apparatus for applying 5-aminolevulinic acid
US6223071B1 (en) 1998-05-01 2001-04-24 Dusa Pharmaceuticals Inc. Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light
EP3143986A1 (en) * 2015-09-21 2017-03-22 Zimmer MedizinSysteme GmbH Hydrophilic gel for topical delivery of 5-aminolevulinic acid and production thereof
ES2860807T3 (es) 2015-10-15 2021-10-05 Dusa Pharmaceuticals Inc Iluminador ajustable para terapia y diagnóstico fotodinámicos
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
US10814114B2 (en) 2015-12-08 2020-10-27 Dusa Pharmaceuticals, Inc. Method and apparatus for applying a topical solution
US10357567B1 (en) * 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy

Similar Documents

Publication Publication Date Title
JP2024542943A5 (https=)
JP5814508B2 (ja) アミノレブリン酸およびその誘導体の使用
JP2025069304A5 (https=)
Lui et al. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study
US20040009212A1 (en) Mucoadhesive thermoresponsive medicament-carrier composition
CN1633285A (zh) 组合物
RU2007115601A (ru) Лечение угрей с использованием производных 5-аминолевулиновой кислоты
KR20100095443A (ko) 광역학 치료 및 진단을 위한 고체 형태로서 5―아미노레불린산 및 그것의 유도체의 용도
JP2007522137A (ja) ざ瘡を治療するための光線力学療法
JP2007522137A5 (https=)
JP2010513500A5 (https=)
KR20110104523A (ko) 관장 제제 및 그것의 용도
RU2009127500A (ru) Фармацевтические композиции и способ лечения воспаления у крупного рогатого скота и других животных
US9561276B2 (en) Method of treating onychomycosis
JP2008501727A (ja) 外用塗布した疎水性緑色ポルフィリンを用いた機能亢進性皮脂腺障害を治療するための光線力学的療法
WO2024088153A1 (zh) 托品酸及其衍生物在制备治疗银屑病药物中的用途
RU2002121636A (ru) Производные индола в качестве антагонистов рецепторов мср-1
WO2013092936A2 (en) Use of 5-aminolevulinic acid and esters, in combination with a vitamin d derivative or analog in photochemotherapy, and their uses in treating acne
JP2008534527A (ja) そう痒の治療および予防のためのオキサプロジンまたは密接に関連する化合物
JP2006514072A (ja) 光線療法における適用のための、並びに皮膚及び/又は関節疾患の処置のためのポルフィリン合成の物質の使用
CN113908271A (zh) 一种凝胶制剂的制备方法
JPWO2019221114A1 (ja) ベタニンまたはその類似化合物を含む皮膚組織修復剤
RU2025132881A (ru) Лечение псориаза с применением низкомолекулярного ингибитора фактора некроза опухоли альфа
WO2025077886A1 (zh) 治疗和/或预防日光性角化病的化合物及方法
JPWO2006085517A1 (ja) クロリン類及びポルフィリン類のpdt用軟膏製剤及び坐剤